BioNexus Gene Lab Corp BGLC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:39 PM EDT
0.60quote price arrow down-0.0008 (-0.1334%)
Volume
4,351
Close
0.5998quote price arrow down-0.2488 (-29.3189%)
Volume
624,820
52 week range
0.31 - 17.88
Loading...
  • Open0.68
  • Day High0.7075
  • Day Low0.58
  • Prev Close0.8486
  • 52 Week High17.88
  • 52 Week High Date07/12/23
  • 52 Week Low0.31
  • 52 Week Low Date11/15/23

Key Stats

  • Market Cap10.597M
  • Shares Out17.67M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.77
  • YTD % Change13.17

KEY STATS

  • Open0.68
  • Day High0.7075
  • Day Low0.58
  • Prev Close0.8486
  • 52 Week High17.88
  • 52 Week High Date07/12/23
  • 52 Week Low0.31
  • 52 Week Low Date11/15/23
  • Market Cap10.597M
  • Shares Out17.67M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.77
  • YTD % Change13.17

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-4.32
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.51M
  • ROE (TTM)-32.21%
  • Revenue (TTM)9.771M
  • Gross Margin (TTM)13.61%
  • Net Margin (TTM)-26.91%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioNexus Gene Lab Corp

 

Profile

MORE
BioNexus Gene Lab Corp., through its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd., focuses on the wholesale of chemical raw material products. The Company is engaged in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. The Company is also engaged in the business of developing and providing non-invasive liquid biopsy tests for the early...
Min Fong Yeat
Chairman of the Board
Chi Yuen Leong
Chief Executive Officer, Director
Meng Wong Yee
President, Director
Lee Su-Leng Tan
Chief Operating Officer
Address
Tower B, Vertical Business Suite, 10-2,
Kuala Lumpur
59200
Malaysia